Carol L. Williams Lcsw Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 2023 Route 9, Ushers Park 9, Round Lake, NY 12151 Phone: 518-406-3119 Fax: 518-406-3119 |
News Archive
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that it has completed patient enrollment in a Phase 1 clinical trial evaluating the intravenous (IV) administration of JX-594, the company's lead product for the treatment of solid tumors. Jennerex expects to report the results from this trial at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in May 2010.
A new technology that relies on a moth-infecting virus and nanomagnets could be used to edit defective genes that give rise to diseases like sickle cell, muscular dystrophy and cystic fibrosis.
Broken bones among older people increase their risk of death for up to 10 years, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Common environmental chemicals assumed to be safe at low doses may act separately or together to disrupt human tissues in ways that eventually lead to cancer, according to a task force of nearly 200 scientists from 28 countries, including one from Oregon State University.
Researchers from the US recently assessed if severe COVID-19 is linked to procoagulant dysfunction of the endothelium and changes in the Tie2-angiopoietin axis. They assessed circulating endothelial markers in a study cohort of 98 patients with mild, moderate, or severe COVID-19. This study is published on the medRxiv* preprint server.
› Verified 8 days ago